Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer.

Coleman Robert,Zhou Ying,Jandial Danielle,Cadieux Benoit, Perth Breast Cancer Institute, Hollywood Consulting Centre

Advances in Therapy（2021）

引用 9|浏览8

关键词

Denosumab,Exploratory bone endpoints,High-risk early breast cancer,Post hoc analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要